-
Views
-
Cite
Cite
Catherine Le Stunff, Agnès Dechartres, Emanuele Miraglia Del Giudice, Philippe Froguel, Pierre Bougnères, A Single-Nucleotide Polymorphism in the p110β Gene Promoter Is Associated with Partial Protection from Insulin Resistance in Severely Obese Adolescents, The Journal of Clinical Endocrinology & Metabolism, Volume 93, Issue 1, 1 January 2008, Pages 212–215, https://doi.org/10.1210/jc.2007-1822
- Share Icon Share
Abstract
Objective: Severe juvenile obesity causes metabolic and cardiovascular complications in adulthood. The catalytic p110β subunit of phosphatidyl-inositol-3 kinase is a major effector of insulin action. We studied the p110β gene as a candidate gene for association with insulin resistance (IR) and fasting glycemia in severely obese children.
Methods: We conducted an association study in 580 severely obese European children (body mass index > 99.6th centile) and 606 nonobese control children, in whom glucose and insulin were measured in the fasting state. The homeostasis model assessment insulin resistance index was used to estimate IR.
Results: We found that a single-nucleotide polymorphism (rs361072) located in the promoter of the p110β gene was associated with fasting glucose (P = 0.0002), insulin (P = 2.6 10−8), and homeostasis model assessment insulin resistance index (P =1 10−9) in the severely obese children. The effect of rs361072 was marginal or not significant in nonobese children.
Conclusions: The C allele of rs361072 attenuates IR in superobese children.